Diagnosis-based risk adjustment for medicare prescription drug plan payments
Robst, J., Levy, JM., & Ingber, M. (2007). Diagnosis-based risk adjustment for medicare prescription drug plan payments. Health Care Financing Review, 28(4), 15-30. http://www.cms.hhs.gov/HealthCareFinancingReview/downloads/07Summerpg15.pdf
Abstract
The 2003 Medicare Prescription Drug, Improvement, and Modernization Act (MMA) created Medicare Part D, a voluntary prescription drug benefit program. The benefit is a government subsidized prescription drug benefit within Medicare. This article focuses on the development of the prescription drug risk-adjustment model used to adjust payments to reflect the health status of plan enrollees
To contact an RTI author, request a report, or for additional information about publications by our experts, send us your request.